Dokter Ruth Reychler, Reumatoloog
0564.772.897 · rovalta.com · 26/09/2026
NORMAL SITUATION
Dokter Ruth Reychler, Reumatoloog
Company — Normal situation.
Financial year 2025 · Closed on 22/12/2025
Net result6,8 k €-92,4 %over 1 year
Gross margin3,6 k €-97,2 %over 1 year
Equity73,6 k €-84,7 %over 1 year
Overview
Identity
Source · BCE/KBODokter Ruth Reychler, Reumatoloog is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0564.772.897
- Legal form
- Private limited company
- Contributed capital
- 73 600,00 €
- Latest accounts
- 22/12/2025
Signals
ProfitableSolid equityPositive cashflowPositive EBITDA
Financials
Source · NBB, 12 filingsTrend over 12 financial years
| 2025 | 2025 | 2024 | 2023 | 2022 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 3,6 k € | -97.2% | 126,1 k € | +4.1% | 121,2 k € | -0.1% | 121,3 k € | +23.2% | 98,5 k € |
| EBITDA | 1,5 k € | -98.8% | 124,8 k € | +4.0% | 120 k € | -0.0% | 120 k € | +22.9% | 97,7 k € |
| Operating result | 1,5 k € | -98.7% | 119,6 k € | +4.1% | 115 k € | +14.8% | 100,1 k € | +63.1% | 61,4 k € |
| Net result | 6,8 k € | -92.4% | 88,5 k € | +3.0% | 86 k € | +71.9% | 50 k € | +18.2% | 42,3 k € |
| Balance sheet | |||||||||
| Equity | 73,6 k € | -84.7% | 480,1 k € | +22.6% | 391,6 k € | +8.6% | 360,5 k € | +15.8% | 311,3 k € |
| Total assets | 73,7 k € | -86.7% | 552,7 k € | +18.6% | 466 k € | +19.7% | 389,4 k € | +17.9% | 330,4 k € |
| Cash | 67,3 k € | -69.1% | 218,1 k € | +560% | 33 k € | -76.5% | 140,4 k € | +118% | 64,5 k € |
| Debts | 0 € | -100% | 69,9 k € | +0.8% | 69,3 k € | +169% | 25,7 k € | +62.6% | 15,8 k € |
Board of directors
Source · NBB, accounts to 22/12/20251 active · 3 ended
Active mandates
RUTH REYCHLER
ActiveEnded mandates
RUTH REYCHLER
EndedRuth Reychler
EndedRUTH JULIA REYCHLER
EndedFinancials
Full financial information
Source · NBB| 2025 | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/10/2025 | 01/10/2024 | 01/10/2023 | 01/10/2022 | 01/10/2021 | 01/10/2020 |
| Closing of the financial year | 22/12/2025 | 30/09/2025 | 30/09/2024 | 30/09/2023 | 30/09/2022 | 30/09/2021 |
| Length of the financial year | 3 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 22/04/2026 | 22/04/2026 | 09/04/2025 | 12/04/2024 | 03/05/2023 | 02/05/2022 |
| General meeting | 22/12/2025 | 08/12/2025 | 28/03/2025 | 29/03/2024 | 31/03/2023 | 08/04/2022 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 12 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 22/12/2025 | 22/12/2025 | 22/04/2026 | Dutch | |
| Micro model | 30/09/2025 | 08/12/2025 | 22/04/2026 | Dutch | |
| Micro model | 30/09/2024 | 28/03/2025 | 09/04/2025 | Dutch | |
| Micro model | 30/09/2023 | 29/03/2024 | 12/04/2024 | Dutch | |
| Micro model | 30/09/2022 | 31/03/2023 | 03/05/2023 | Dutch | |
| Micro model | 30/09/2021 | 08/04/2022 | 02/05/2022 | Dutch | |
| Micro model | 30/09/2020 | 26/03/2021 | 12/04/2021 | Dutch | |
| Micro model | 30/09/2019 | 27/03/2020 | 01/04/2020 | Dutch | |
| Micro model | 30/09/2018 | 29/03/2019 | 24/04/2019 | Dutch | |
| Micro model | 30/09/2017 | 23/03/2018 | 30/04/2018 | Dutch | |
| Abridged model | 30/09/2016 | 24/03/2017 | 12/04/2017 | Dutch | |
| Abridged model | 30/09/2015 | 25/03/2016 | 29/03/2016 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 22/12/20251 active · 3 ended
Active mandates
RUTH REYCHLER
ActiveEnded mandates
RUTH REYCHLER
EndedRuth Reychler
EndedRUTH JULIA REYCHLER
EndedOwnership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Dissolution23/01/2026RUBRIEK EINDE (STOPZETTING, INTREKKING STOPZETTING, NIETIGHEID, GER. AK., GERECHTELIJKE REORGANISATIE, ENZ... - ONTSLAGEN - BENOEMINGEN
- Mandates22/12/2021WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
- Other02/03/2015DIVERSEN
- Other20/10/2014RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 20256,8 k €↓
- 2025Annual accounts 202588,5 k €↑
- 2025Name changeDokter Ruth Reychler,reumatoloog in vereffening
- 2024Annual accounts 202486 k €↑
- 2023Annual accounts 202350 k €↑
- 2022Annual accounts 202242,3 k €↓
- 2021Annual accounts 202144,6 k €↑
- 2021Name changeDokter Ruth Reychler,reumatoloog
- 2020Annual accounts 202035,2 k €↓
- 2019Annual accounts 201939,9 k €↑
- 2018Annual accounts 201833,1 k €↑
- 2017Annual accounts 20172,6 k €↓
- 2016Annual accounts 201631,4 k €↑
- 2015Annual accounts 201518,6 k €